Vertex Pharmaceuticals Incorporated Earnings

Vertex Pharmaceuticals Incorporated’s revenue jumped 10.82% since last year same period to $3227.1Mn in the Q4 2025. On a quarterly growth basis, Vertex Pharmaceuticals Incorporated has generated 4.9% jump in its revenue since last 3-months.

Vertex Pharmaceuticals Incorporated’s net profit jumped 30.46% since last year same period to $1191.1Mn in the Q4 2025. On a quarterly growth basis, Vertex Pharmaceuticals Incorporated has generated 9.99% jump in its net profits since last 3-months.

Vertex Pharmaceuticals Incorporated’s net profit margin jumped 17.72% since last year same period to 36.91% in the Q4 2025. On a quarterly growth basis, Vertex Pharmaceuticals Incorporated has generated 4.86% jump in its net profit margins since last 3-months.

Vertex Pharmaceuticals Incorporated’s earning per share (EPS) estimates for the current quarter stand at 5.12 - a 11.06% jump from last quarter’s estimates.

Vertex Pharmaceuticals Incorporated’s earning per share (EPS) estimates for the current year stand at 5.12.

Vertex Pharmaceuticals Incorporated’s earning per share (EPS) jumped 26.38% since last year same period to 5.03 in the Q4 2025. This indicates that the Vertex Pharmaceuticals Incorporated has generated 26.38% annual rate of jump in its earning per share (EPS) in the last 4 quarters.